- Home
- URG vs BNTC Comparison
URG vs BNTC Comparison
Compare URG & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- URG
- BNTC
- Stock Information
- Founded
- URG 2004
- BNTC 1995
- Country
- URG United States
- BNTC United States
- Employees
- URG N/A
- BNTC N/A
- Industry
- URG Precious Metals
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- URG Basic Materials
- BNTC Health Care
- Exchange
- URG Nasdaq
- BNTC Nasdaq
- Market Cap
- URG 326.6M
- BNTC 339.8M
- IPO Year
- URG N/A
- BNTC N/A
- Fundamental
- Price
- URG $0.90
- BNTC $16.11
- Analyst Decision
- URG Strong Buy
- BNTC Strong Buy
- Analyst Count
- URG 2
- BNTC 7
- Target Price
- URG $2.45
- BNTC $24.43
- AVG Volume (30 Days)
- URG 5.5M
- BNTC 37.6K
- Earning Date
- URG 05-05-2025
- BNTC 05-12-2025
- Dividend Yield
- URG N/A
- BNTC N/A
- EPS Growth
- URG N/A
- BNTC N/A
- EPS
- URG N/A
- BNTC N/A
- Revenue
- URG $16,494,000.00
- BNTC N/A
- Revenue This Year
- URG $86.92
- BNTC N/A
- Revenue Next Year
- URG $36.42
- BNTC N/A
- P/E Ratio
- URG N/A
- BNTC N/A
- Revenue Growth
- URG 34.78
- BNTC N/A
- 52 Week Low
- URG $0.73
- BNTC $4.75
- 52 Week High
- URG $1.90
- BNTC $15.97
- Technical
- Relative Strength Index (RSI)
- URG 49.80
- BNTC 70.37
- Support Level
- URG $0.78
- BNTC $14.90
- Resistance Level
- URG $0.95
- BNTC $15.97
- Average True Range (ATR)
- URG 0.07
- BNTC 1.03
- MACD
- URG 0.02
- BNTC 0.32
- Stochastic Oscillator
- URG 76.59
- BNTC 85.59
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is y is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.